Home

Home

Mammograms or MRI scans?

X-ray based mammograms detect only 56% of early lesions in high risk women compared with 92% when MRI scanning (mostly used for brain scans), according to a study by Christiane Kuhl and colleagues at the University of Bonn (pub: the Lancet. 8/07).

Almost all breast cancers begin with non-invasive cancerous cells in the milk ducts. ‘If you picked up all cases of ductal carcinoma in situ [DCIS] you’d prevent virtually all cases of breast cancer. Our finding that MRI is superior to mammography in detecting it turns things upside down,’ said Dr Kuhl.

During the study, 7,319 women were referred from screening programmes after they had breast cancer or had a family history of the cancer. After scanning, 167 women were diagnosed with DCIS, 92% through the MRI but only 56% by mammogram. In women with the most severe DCIS – most likely to lead to a diagnosis of breast cancer – MRI detected 98% and mammography 52%.
Due to costs and time, generally only younger women at high risk of breast cancer are offered MRI scans. However, there is also concern that more rigorous screening would over-diagnose a condition that, in around 75% of cases, does not lead to cancer.
Some specialists point out that the study was only based on a small sample of women, younger than 50-70 years old – a group in which MRI is more effective due to the denser breast tissue. Others suggest further studies be carried out.

This article was published on 10/30/2007

Search

 

Service

Company News

Technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Meet us at MEDICA! Hall 7 Stand 15

The European Hospital team will be happy to hear about your research, products, R&D or trials and launches, hospital management issues, or any other aspects of your work, so that we can discuss your editorial ideas. We will also be pleased to help with any PR or advertising queries.